Figure 3From: Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancerCorrelations between PCDH8 methylation and progression-free survival in NMIBC patients. Patients with PCDH8 methylated showed significantly shorter progression-free survival than patients without (P < 0.0001, log-rank test).Back to article page